A comparison of the ability of newly-developed bispyridinium oxime K203 and currently available oximes (trimedoxime, obidoxime, HI-6) to counteract the acute neurotoxicity of soman in rats

References

• Bajgar J. 2004. Organophosphate/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 38:151–216.
   PubMed Web of Science ®Google Scholar
• Carpentier P, Delamanche LS, Le Bert M, Blanchet G, Bouchard C. 1990. Seizure-related opening of the blood-brain barrier induced by soman: possible correlation with the acute neuropathology observed in poisoned rats. Neurotoxicology 11:493–508.
   PubMed Web of Science ®Google Scholar
• Cassel G, Karlsson L, Waara L, Wee Ang K, Goransson-Nyberg A. 1997. Pharmacokinetics and effects of HI-6 in blood and brain of soman-intoxicated rats: a microdialysis study. Eur J Pharmacol 332:43–52.
   PubMed Web of Science ®Google Scholar
• Clement JG. 1992. Central activity of acetylcholinesterase oxime reactivators. Toxicol Appl Pharmacol 112:104–109.
   PubMed Web of Science ®Google Scholar
• Dawson RM.1994. Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 14: 317–331.
   PubMed Web of Science ®Google Scholar
• Frantik E, Hornychova M. 1995. Clustering of neurobehavioral measures of toxicity. Homeostasis 36:19–25.
   Google Scholar
• Grange-Messent V, Bouchard C, Jamme M, Lallement G, Foguin A, Carpentier P. 1999. Seizure-related opening of the blood-brain barrier produced by the anticholinesterase compound, soman: new ultrastructural observations. Cell Mol Biol 45:1–14.
   PubMed Web of Science ®Google Scholar
• Inns RH, Leadbeater L. 1983. The efficacy of bispyridinium derivatives in the treatment of organophosphate poisoning in the guinea-pig. J Pharm Pharmacol 35:427–432.
   PubMed Web of Science ®Google Scholar
• Jokanovic M, Prostran M. 2009. Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. Curr Med Chem 16:2177–2188.
   PubMed Web of Science ®Google Scholar
• Kassa J. 2002. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 40:803–816.
   PubMed Web of Science ®Google Scholar
• Kassa J, Bajgar J. 1998. The influence of the choice of anticholinergic drugs on the efficacy of BI-6 oxime in the treatment of soman poisoning in rats. Homeostasis 38:190–192.
   Google Scholar
• Kassa J, Karasova J, Musilek K, Kuca K. 2008. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Toxicology 243:311–316.
   PubMed Web of Science ®Google Scholar
• Kassa J, Karasova J, Vasina L, Bajgar J, Kuca K, Musilek K. 2009. A comparison of neuroprotective efficacy of newly developed oximes (K203, K206) and commonly used oximes (obidoxime, HI-6) in tabun-poisoned rats. Drug Chem Toxicol 32:128–138.
   PubMed Web of Science ®Google Scholar
• Kloog Y, Galron R, Sokolovsky M. 1986. Bisquaternary pyridinium oximes as presynaptic agonists and postsynaptic antagonists of muscarinic receptors. J Neurochem 46:767–772.
   PubMed Web of Science ®Google Scholar
• Lallement G, Clarencon D, Bronchier G, Baubichon D, Galonnier M, Blanchet G, Mestries JC. 1997. Eficacy of atropine/pralidoxime/diazepam or atropine/HI-6/prodiazepam in primates intoxicated by soman. Pharmacol Biochem Behav 56:325–332.
   PubMed Web of Science ®Google Scholar
• Laufer R, Kalasz H, Musilek K, Szegi P, Darvas F, Kuca K, Tekes K. 2010. Synthesis, antidotal effects and HLC behavior of some novel pyridinium aldoximes. Curr Org Chem 14:447–456.
   Web of Science ®Google Scholar
• Lorke DE, Kalasz H, Petroianu GA, Tekes K. 2008. Entry of oximes into the brain: a review. Curr Med Chem 15:743–753.
   PubMed Web of Science ®Google Scholar
• Lundy PM, Raveh L, Amitai G. 2006. Development of the bisquaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning. Toxicol Rev 25:231–243.
   PubMedGoogle Scholar
• Marrs TC. 1993. Organophosphate poisoning. Pharmacol Ther 58:51–66.
   PubMed Web of Science ®Google Scholar
• Marrs TC, Rice P, Vale JA. 2006. The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Toxicol Rev 25:297–323.
   PubMedGoogle Scholar
• McDonough JH Jr, Shih T-M. 1997. Neuropharmacological modulation of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev 21:559–579.
   PubMed Web of Science ®Google Scholar
• McDonough JH Jr, Zoeffel LD, McMonagle J, Copeland TL, Smith CD, Shih T-M. 2000. Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea-pigs. Epilepsy Res 38:1–14.
   PubMed Web of Science ®Google Scholar
• Moser VC, Tilson H, McPhail RC, Becking GC, Cuomo V, Frantik E, Kulig BM, Winneke, G. 1997. The IPCS collaborative study on neurobehavioral screening methods: II. Protocol design and testing procedures. Neurotoxicology 18:929–938.
   PubMed Web of Science ®Google Scholar
• Musilek K, Holas O, Kuca K, Jun D, Dohnal V, Opletalova V, Dolezal M. 2008. Synthesis of monooxime-monocarbamoyl bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesterase. J Enz Inhib Med Chem 23:70–76.
   PubMed Web of Science ®Google Scholar
• Sakurada K, Matsubara K, Shimizu K, Shiono H, Seto Y, Tsuge K, Toshibo M, Sakai I, Mukoyama H, Takatori T. 2003. Pralidoxime iodide (2-PAM) penetrates across the blood-brain barrier. Neurochem Res 28:1401–1407.
   PubMed Web of Science ®Google Scholar
• Shih T-M. 1993. Comparison of several oximes on reactivation of soman-induced blood, brain and tissue cholinesterase activity in rats. Arch Toxicol 7:637–646.
   Google Scholar
• Taylor P. 1996. Anticholinesterase agents. In: Hardman JG, Limbird LE, editors. The pharmacological basis of therapeutics. New York: McGraw Hill. pp 161–176.
   Google Scholar
• Van Helden HPM, Groen B, Moor E, Westerink BHC, Bruijnzeel PLB. 1998. New generic approach to the treatment of organophosphate poisoning: adenosine receptor mediated inhibition of ACh-release. Drug Chem Toxicol 21(suppl 1):171–181.
   PubMedGoogle Scholar
• Wiener SW, Hoffman RS.2004. Nerve agents: a comprehensive review. J Intensive Care Med 19: 22–37.
   PubMedGoogle Scholar